Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0IF0T
|
|||
Drug Name |
Aminopyrimidine derivative 7
|
|||
Synonyms |
PMID26293650-Compound-44
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
Myrexis
|
|||
Structure |
Download2D MOL |
|||
Formula |
C26H27N5O3
|
|||
Canonical SMILES |
C1COCCC1OC2=C(C=C(C=C2)C3=NC(=NC=C3)NC4=CC=C(C=C4)N5CCOCC5)C#N
|
|||
InChI |
1S/C26H27N5O3/c27-18-20-17-19(1-6-25(20)34-23-8-13-32-14-9-23)24-7-10-28-26(30-24)29-21-2-4-22(5-3-21)31-11-15-33-16-12-31/h1-7,10,17,23H,8-9,11-16H2,(H,28,29,30)
|
|||
InChIKey |
BWABTWGSXHTHCG-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | NF-kappa-B-activating kinase (TBK1) | Target Info | Inhibitor | [1] |
Target's Patent Info | NF-kappa-B-activating kinase (TBK1) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | TBK1 inhibitors: a review of patent literature (2011 - 2014).Expert Opin Ther Pat. 2015;25(12):1385-96. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.